AGTX - Agentix Corp.
0.042
-0.007 -15.476%
Share volume: 40,000
Last Updated: 03-17-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$0.05
-0.01
-0.13%
Summary score
40%
Profitability
35%
Dept financing
43%
Liquidity
0%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2022 - 30-Sep-2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-671.22%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
18516.69%
Debt ratio change over timeo
0%
Current Ratio
0.05%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Sep-2025 - 30-Sep-2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-2295.08%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
63390.67%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Sep-2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-1012.99%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
54790.43%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Sep-2022 - 30-Sep-2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AGTX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 6.7% | 0% |
| Return on assets | -671.22% | 2.83% | 3.07% | 1.7% |
| Return on sales | 0% | 25.4% | 24.37% | 18.4% |
| Return on invested capital | 0% | 0% | 4.11% | 0% |
| Profitability | 0% | 48% | 99% | 32% |
| Total debt ratio | 18516.69% | 92.6% | 65.35% | 41.87% |
| Debt ratio change over time | 0% | 0% | 15.98% | 0% |
| Dept financing | 25% | 0% | 25% | 0% |
| Current Ratio | 0% | 1.14% | 1.55% | 2.68% |
| Quick Ratio | 0% | 0.9% | 1.4% | 2.03% |
| Cash Position Ratio | 0% | 0.36% | 0.64% | 0.9% |
| Liquididy | 1% | 64% | 48% | 70% |
| Short-term ratios | AGTX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -2295.08% | 2.39% | 3.95% | -0.19% |
| Return on sales | 0% | 27.57% | 25.03% | -2.46% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 40% | 48% | 0% |
| Total debt ratio | 63390.67% | 90.44% | 61.54% | 37.99% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 0% | 0% | 0% |
| Current Ratio | 0% | 1.14% | 1.55% | 2.68% |
| Quick Ratio | 0% | 0.9% | 1.4% | 2.03% |
| Cash Position Ratio | 0% | 0.36% | 0.64% | 0.9% |
| Liquididy | 0% | 32% | 49% | 75% |